Adhera Therapeutics, Inc. (ATRX)

Adhera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-2.53	2.35	-7.78	-5.54	-12.64	-16.75
Depreciation & Amortization	1.64	1.81	0.4	0.4	0.08	0.33
Share-Based Compensation	0	0	0	0.01	0.77	0
Other Operating Activities	0.08	-5.58	6.72	4.54	3.06	6.81
Operating Cash Flow	-0.81	-1.42	-0.67	-0.59	-8.74	-9.61
Capital Expenditures	0	0	0	0	0	-0.07
Investing Cash Flow	0	0	0	0	0	-0.07
Common Stock Issued	5.06	5.06	0.12	0.02	0	13.89
Share Repurchases	-0	-0	-0.74	-0.54	-0.1	-0.25
Other Financing Activities	-4.35	-3.69	-0.12	-0.02	4.77	-0.64
Financing Cash Flow	0.71	1.37	0.74	0.54	4.87	13.5
Net Cash Flow	-0.1	-0.04	0.07	-0.05	-3.87	3.81
Free Cash Flow	-0.81	-1.42	-0.67	-0.59	-8.74	-9.69
Free Cash Flow Margin	-	-	-	-	-3467.46%	-12713.36%
Free Cash Flow Per Share	-0.19	-0.61	-1.02	-1.08	-16.12	-17.87

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.